| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |